Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as…
What to know about BSX
Boston Scientific Corporation is a large Healthcare company with a solid overall financial profile. It scores well on growth and sentiment, but risk is worth keeping an eye on.
Should you consider BSX?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Boston Scientific Corporation is a large-cap Healthcare company with a solid overall financial profile — it ranks in the top quarter of its Healthcare peers (5 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
Growth is a clear strength — revenue and earnings are expanding faster than most peers, signalling strong demand for the company's products or services.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
Overall, this is a well-rounded stock with multiple genuine strengths and few obvious weaknesses. It may suit investors looking for a reliable holding in the Healthcare space.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how BSX compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 18.95 | Above avg |
| Forward P/E | 12.16 | Above avg |
| PEG Ratio | 0.57 | Top 25% |
| Price to Sales | 3.27 | Above avg |
| Price to Book | 2.60 | Above avg |
| EV/EBITDA | 14.46 | Above avg |
| Earnings Yield | 5.28% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 68.94% | Top 25% |
| Operating Margin | 20.60% | Above avg |
| Net Profit Margin | 17.29% | Above avg |
| Return on Equity | 14.66% | Average |
| Return on Invested Capital | 6.07% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 11.60% | Above avg |
| Revenue Growth (3Y CAGR) | 16.54% | Top 25% |
| EPS Growth (YoY) | 100.00% | Top 25% |
| Free Cash Flow Growth | 43.93% | Top 25% |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.90 | Top 25% |
| Debt to Equity | 0.42 | Top 25% |
| Interest Coverage | 10.70 | Above avg |
| Altman Z-Score | 3.12 | Average |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | 0.00% | Top 25% |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 4.90% | Above avg |
| OCF to Sales | 21.06% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.56 | Top 25% |
| Volatility (30-Day) | 47.62% | Below avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.87% | Average |
| Avg. Analyst Rating | 1.48 | Top 25% |
| Target Upside % | 70.24% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 67.32B | Above avg |
How does BSX compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to BSX — based on their financial profile.